Trade Summary

5 days ago, Mazumdar Claire, serving as Chief Executive Officer at Bicara Therapeutics Inc. (BCAX), sold 10,000 shares at $28.42 per share, for a total transaction value of $284,198.38. Following this transaction, Mazumdar Claire now holds 362,152 shares of BCAX.

This sale represents a 2.69% decrease in Mazumdar Claire's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, July 10, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 14, 2026 at 4:22 PM ET, 4 days after the trade was made.

Bicara Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.